MedTrace Logo

Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer

NCT04515888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2021-11-04

No results posted yet for this study

Summary

In this study, investigator propose to assess the prevalence of pelvic static disorders in women undergoing adjuvant hormone therapy for localized breast cancer and to assess the overall quality of life in these patients

Conditions

Interventions

OTHER

PFDI-20 / PFIQ-7 questionnaires

PFDI-20 / PFIQ-7 questionnaires (one shot)

Sponsors & Collaborators

  • Institut du Cancer de Montpellier - Val d'Aurelle

    lead OTHER

Principal Investigators

  • Laure DELMOND, MD · ICM Val d'Aurelle

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-18
Primary Completion
2021-02-12
Completion
2021-07-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04515888 on ClinicalTrials.gov